Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Niels E. A. Vogel is active.

Publication


Featured researches published by Niels E. A. Vogel.


The New England Journal of Medicine | 2016

Randomized Trial of a Lifestyle Program in Obese Infertile Women

Meike Mutsaerts; Anne M. van Oers; Henk Groen; Jan M. Burggraaff; Walter K. H. Kuchenbecker; Denise A. M. Perquin; Carolien A. M. Koks; Ron van Golde; Eugenie M. Kaaijk; Jaap M. Schierbeek; G.J.E. Oosterhuis; Frank J. Broekmans; Wanda J. E. Bemelmans; Cornelis B. Lambalk; M.F.G. Verberg; Fulco van der Veen; Nicole F. Klijn; Patricia E.A.M. Mercelina; Yvonne M. van Kasteren; Annemiek W. Nap; Egbert A. Brinkhuis; Niels E. A. Vogel; Robert J. A. B. Mulder; Ed T. C. M. Gondrie; Jan Bruin; J. Marko Sikkema; Mathieu H.G. de Greef; Nancy C. W. ter Bogt; Jolande A. Land; Ben Willem J. Mol

BACKGROUND Small lifestyle-intervention studies suggest that modest weight loss increases the chance of conception and may improve perinatal outcomes, but large randomized, controlled trials are lacking. METHODS We randomly assigned infertile women with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 29 or higher to a 6-month lifestyle intervention preceding treatment for infertility or to prompt treatment for infertility. The primary outcome was the vaginal birth of a healthy singleton at term within 24 months after randomization. RESULTS We assigned women who did not conceive naturally to one of two treatment strategies: 290 women were assigned to a 6-month lifestyle-intervention program preceding 18 months of infertility treatment (intervention group) and 287 were assigned to prompt infertility treatment for 24 months (control group). A total of 3 women withdrew consent, so 289 women in the intervention group and 285 women in the control group were included in the analysis. The discontinuation rate in the intervention group was 21.8%. In intention-to-treat analyses, the mean weight loss was 4.4 kg in the intervention group and 1.1 kg in the control group (P<0.001). The primary outcome occurred in 27.1% of the women in the intervention group and 35.2% of those in the control group (rate ratio in the intervention group, 0.77; 95% confidence interval, 0.60 to 0.99). CONCLUSIONS In obese infertile women, a lifestyle intervention preceding infertility treatment, as compared with prompt infertility treatment, did not result in higher rates of a vaginal birth of a healthy singleton at term within 24 months after randomization. (Funded by the Netherlands Organization for Health Research and Development; Netherlands Trial Register number, NTR1530.).


Human Reproduction | 2008

Cumulative pregnancy rates after sequential treatment with modified natural cycle IVF followed by IVF with controlled ovarian stimulation

M. J. Pelinck; H. M. Knol; Niels E. A. Vogel; Eric Arts; Arnold Simons; M. J. Heineman; Annemieke Hoek

BACKGROUND In modified natural cycle IVF (MNC-IVF), treatment is aimed at using the one follicle that spontaneously develops to dominance, using a GnRH-antagonist together with gonadotrophins in the late follicular phase only. The MNC-IVF is of interest because of its low-risk and patient-friendly profile. The effect of application of MNC-IVF preceding standard IVF with ovarian stimulation on overall results is unknown. METHODS This single-center cohort study provides follow-up of an earlier study in which nine cycles of MNC-IVF were offered to 268 patients. Ongoing pregnancy rates and live birth rates, as well as time-to-pregnancy after controlled ovarian stimulation-IVF (COS-IVF) following MNC-IVF, were evaluated. RESULTS Actual observed cumulative ongoing pregnancy rates and live birth rates after sequential treatment with MNC-IVF followed by COS-IVF were 51.5 (95% CI: 45.4-57.6) and 50.0% (95% CI: 43.9-56.1) per patient, of which 8.0 and 6.7% were twins. Median time to ongoing pregnancy was 28.8 weeks. Including treatment-independent pregnancies, cumulative ongoing pregnancy rate was 56.7% (95% CI: 50.7-62.8). CONCLUSIONS Sequential treatment with MNC-IVF followed by COS-IVF does not appear to compromise overall success rates, while twin pregnancy rate is low. Because of its patient-friendly and low-risk profile, it seems appropriate to perform MNC-IVF preceding COS-IVF.


PLOS ONE | 2018

Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: A randomized controlled trial

Lotte van Dammen; Vincent Wekker; Anne M. van Oers; Meike Mutsaerts; Rebecca C. Painter; Aeilko H. Zwinderman; Henk Groen; Cornelieke van de Beek; Anneke C. Muller Kobold; Walter K. H. Kuchenbecker; Ron van Golde; G.J.E. Oosterhuis; Niels E. A. Vogel; Ben Willem J. Mol; Tessa J. Roseboom; Annemieke Hoek; Nigel K. Stepto

Background The prevalence of obesity, an important cardiometabolic risk factor, is rising in women. Lifestyle improvements are the first step in treatment of obesity, but the success depends on factors like timing and motivation. Women are especially receptive to advice about lifestyle before and during pregnancy. Therefore, we hypothesize that the pre-pregnancy period provides the perfect window of opportunity to improve cardiometabolic health and quality of life of obese infertile women, by means of a lifestyle intervention. Methods and findings Between 2009–2012, 577 infertile women between 18 and 39 years of age, with a Body Mass Index of ≥ 29 kg/m2, were randomized to a six month lifestyle intervention preceding infertility treatment, or to direct infertility treatment. The goal of the intervention was 5–10% weight loss or a BMI < 29 kg/m2. Cardiometabolic outcomes included weight, waist- and hip circumference, body mass index, systolic and diastolic blood pressure, fasting glucose and insulin, HOMA-IR, hs-CRP, lipids and metabolic syndrome. All outcomes were measured by research nurses at randomization, 3 and 6 months. Self-reported quality of life was also measured at 12 months. Three participants withdrew their informed consent, and 63 participants discontinued the intervention program. Intention to treat analysis was conducted. Mixed effects regression models analyses were performed. Results are displayed as estimated mean differences between intervention and control group. Weight (-3.1 kg 95% CI: -4.0 to -2.2 kg; P < .001), waist circumference (-2.4 cm 95% CI: -3.6 to -1.1 cm; P < .001), hip circumference (-3.0 95% CI: -4.2 to -1.9 cm; P < .001), BMI (-1.2 kg/m2 95% CI: -1.5 to -0.8 kg/m2; P < .001), systolic blood pressure (-2.8 mmHg 95% CI: -5.0 to -0.7 mmHg; P = .01) and HOMA-IR (-0.5 95% CI: -0.8 to -0.1; P = .01) were lower in the intervention group compared to controls. Hs-CRP and lipids did not differ between groups. The odds ratio for metabolic syndrome in the intervention group was 0.53 (95% CI: 0.33 to 0.85; P < .01) compared to controls. Physical QoL scores were higher in the lifestyle intervention group (2.2 95% CI: 0.9 to 3.5; P = .001) while mental QoL scores did not differ. Conclusions In obese infertile women, a lifestyle intervention prior to infertility treatment improves cardiometabolic health and self-reported physical quality of life (LIFEstyle study: Netherlands Trial Register: NTR1530).


Human Reproduction | 2017

Corrigendum: Effectiveness of lifestyle intervention in subgroups of obese infertile women : A subgroup analysis of a RCT

A.M. van Oers; Henk Groen; Meike Mutsaerts; Jan M. Burggraaff; Walter K. H. Kuchenbecker; Denise A. M. Perquin; Carolien A. M. Koks; R. van Golde; Eugenie M. Kaaijk; Jaap M. Schierbeek; G.J.E. Oosterhuis; F. J. Broekmans; Niels E. A. Vogel; Jolande A. Land; B.W. Mol; Annemieke Hoek; LIFEstyle Study Grp

Study question: Do age, ovulatory status, severity of obesity and body fat distribution affect the effectiveness of lifestyle intervention in obese infertile women? Summary answer: We did not identify a subgroup in which lifestyle intervention increased the healthy live birth rate however it did increase the natural conception rate in anovulatory obese infertile women. What is known already: Obese women are at increased risk of infertility and are less likely to conceive after infertility treatment. We previously demonstrated that a 6-month lifestyle intervention preceding infertility treatment did not increase the rate of healthy live births (vaginal live birth of a healthy singleton at term) within 24 months of follow-up as compared to prompt infertility treatment in obese infertile women. Natural conceptions occurred more frequently in women who received a 6-month lifestyle intervention preceding infertility treatment. Study design, size, duration: This is a secondary analysis of a multicenter RCT (randomized controlled trial), the LIFEstyle study. Between 2009 and 2012, 577 obese infertile women were randomly assigned to a 6-month lifestyle intervention followed by infertility treatment (intervention group) or to prompt infertility treatment (control group). Subgroups were predefined in the study protocol, based on frequently used cut-off values in the literature: age (≥ 36 or < 36 years), ovulatory status (anovulatory or ovulatory), BMI (≥ 35 or < 35 kg/ m) and waist-hip (WH) ratio (≥ 0.8 or < 0.8). Participants/materials, setting, methods: Data of 564 (98%) randomized women who completed follow-up were analyzed. We studied the effect of the intervention program in various subgroups on healthy live birth rate within 24 months, as well as the rate of overall live births (live births independent of gestational age, mode of delivery and health) and natural conceptions conceived within 24 months. Live birth rates included pregnancies resulting from both treatment dependent and natural conceptions. Logistic regression models with randomization group, subgroup and the interaction between randomization group and subgroup were used. Significant interaction was defined as a P-value <0.1. Main results and the role of chance: Neither maternal age, ovulatory status nor BMI had an impact on the healthy live birth rate within 24 months, nor did they influence the overall live birth rate within 24 months after randomization. WH ratio showed a significant interaction with the effect of lifestyle intervention on healthy live birth rate (P = 0.05), resulting in a lower


The New England Journal of Medicine | 2007

In vitro fertilization with preimplantation genetic screening

Sebastiaan Mastenbroek; Moniek Twisk; Jannie van Echten-Arends; Birgit Sikkema-Raddatz; Johanna C. Korevaar; Harold R. Verhoeve; Niels E. A. Vogel; Eus G. J. M. Arts; Jan W.A de Vries; Patrick M. Bossuyt; Charles H.C.M. Buys; Maas Jan Heineman; Sjoerd Repping; Fulco van der Veen


Human Reproduction | 2007

Cumulative pregnancy rates after a maximum of nine cycles of modified natural cycle IVF and analysis of patient drop-out: a cohort study

M. J. Pelinck; Niels E. A. Vogel; Eric Arts; Arnold Simons; M. J. Heineman; Annemieke Hoek


Human Reproduction | 2006

Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study

M. J. Pelinck; Niels E. A. Vogel; Annemieke Hoek; Arnold Simons; Eus G. J. M. Arts; M.H. Mochtar; S.N. Beemsterboer; M.N. Hondelink; M. J. Heineman


Fertility and Sterility | 2003

Effectiveness of the modified natural cycle ICSI: results of a pilot study

Niels E. A. Vogel; M. J. Pelinck; Eus G. J. M. Arts; Annemieke Hoek; Arnold Simons; Maas Jan Heineman


Human Reproduction | 2016

Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT

A.M. van Oers; Henk Groen; Meike Mutsaerts; Jan M. Burggraaff; Walter K. H. Kuchenbecker; Denise A. M. Perquin; C.A.M. Koks; R. van Golde; Eugenie M. Kaaijk; Jaap M. Schierbeek; G.J.E. Oosterhuis; Frank J. Broekmans; Niels E. A. Vogel; Jolande A. Land; B.W. Mol; Annemieke Hoek


Fertility and Sterility | 2017

Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial

Angelo B. Hooker; Robert de Leeuw; Peter M. van de Ven; Erica A. Bakkum; Andreas L. Thurkow; Niels E. A. Vogel; Huib van Vliet; Marlies Y. Bongers; Mark Hans Emanuel; Annelies E.M. Verdonkschot; Hans A.M. Brölmann; Judith A.F. Huirne

Collaboration


Dive into the Niels E. A. Vogel's collaboration.

Top Co-Authors

Avatar

Annemieke Hoek

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Arnold Simons

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

M. J. Pelinck

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eus G. J. M. Arts

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Henk Groen

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Meike Mutsaerts

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Walter K. H. Kuchenbecker

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Eric Arts

University Medical Center Groningen

View shared research outputs
Researchain Logo
Decentralizing Knowledge